FDA moves toward easing restrictions on certain peptides BioPharma Dive BPC 157 Peptide Therapy Beverly Hills Tissue & Gut Repair Should You Try MOTS c and BPC 157 Longevity Peptides? Separating Truth from Hype with Human Data Studies The U.S. Food and Drug Administration is moving toward allowing compounding pharmacies to produce more than a dozen injectable peptides that were banned because of potentially significant safety risks, the New York